000 01228 a2200325 4500
005 20250515065628.0
264 0 _c20071102
008 200711s 0 0 eng d
022 _a0007-1188
024 7 _a10.1038/sj.bjp.0707272
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPodesser, B K
245 0 0 _aNitric oxide homeostasis as a target for drug additives to cardioplegia.
_h[electronic resource]
260 _bBritish journal of pharmacology
_cAug 2007
300 _a930-40 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aCalcium Channel Blockers
_xpharmacology
650 0 4 _aCardioplegic Solutions
_xpharmacology
650 0 4 _aFree Radical Scavengers
_xpharmacology
650 0 4 _aHomeostasis
_xdrug effects
650 0 4 _aHumans
650 0 4 _aModels, Biological
650 0 4 _aNitric Oxide
_xmetabolism
650 0 4 _aNitric Oxide Synthase Type I
_xmetabolism
650 0 4 _aReperfusion Injury
_xphysiopathology
700 1 _aHallström, S
773 0 _tBritish journal of pharmacology
_gvol. 151
_gno. 7
_gp. 930-40
856 4 0 _uhttps://doi.org/10.1038/sj.bjp.0707272
_zAvailable from publisher's website
999 _c17032260
_d17032260